Quarterly Activity Chart
Adds vs. Reduces by Quarter
PaperPanda Equity Terminal
KROS —
KEROS THERAPEUTICS INC
CUSIP: 492327101 · Held by 2 superinvestors · Combined value: $26,260,450
Latest News
Loading financials…
| # | Investor | % of Portfolio | Value ($) | Shares | Recent Activity | Share Change |
|---|---|---|---|---|---|---|
| 1 | Ken Griffin | 0.0% | $14,213,723 | 698,120 | ADD | +453,276 |
| 2 | Jim Simons | 0.0% | $12,046,727 | 591,686 | ADD | +436,986 |
| Investor | Activity | Share Change | % Change |
|---|---|---|---|
| Jim Simons | ADD | +436,986 | +282.5% |
| Ken Griffin | ADD | +453,276 | +185.1% |
| Investor | Activity | Share Change | % Change |
|---|---|---|---|
| Jim Simons | ADD | +8,100 | +5.5% |
| Ken Griffin | ADD | +112,646 | +85.2% |
Who Owns KROS? Superinvestor Holdings
KEROS THERAPEUTICS INC is held by 2 tracked superinvestors, with a combined position value of $26 million . The largest positions are held by Ken Griffin (0.0% of portfolio), Jim Simons (0.0% of portfolio).
In the most recent quarter, 2 superinvestors added or initiated positions.